Syntax Research’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43K Sell
9
-12,664
-100% -$1.88M ﹤0.01% 173
2026
Q1
$1.86M Sell
12,673
-893
-7% -$138K 1.18% 34
2025
Q4
$2.1M Sell
13,566
-150
-1% -$22.5K 1.3% 28
2025
Q3
$1.91M Buy
+13,716
New +$1.86M 1.23% 27

Other funds holding XLV

Syntax Research's XLV Position: Q2 2026 in Review

Syntax Research reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 100% in Q2 2026, selling an estimated $1.88M and leaving 9 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Syntax Research first reported a position in XLV in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.1M in Q4 2025. 1,856 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Syntax Research held 9 shares of State Street Health Care Select Sector SPDR ETF worth $1.43K as of Q2 2026.
  • Syntax Research sold 12,664 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $1.88M.
  • State Street Health Care Select Sector SPDR ETF made up ﹤0.01% of Syntax Research's portfolio in Q2 2026, its #173 holding.
  • Syntax Research first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2025 and has held it in 4 quarters since.
  • Syntax Research's State Street Health Care Select Sector SPDR ETF position peaked at $2.1M in Q4 2025.
  • 1,856 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.